Showing results (211-220 of 322) with videos related to
Sort By:
Pageof 33
Blood Advances|April 21, 2021
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysisHyehyun Jeong, Hyungwoo Cho, Hyeyeong Kim, et al.International Journal of Hematology|January 7, 2003
Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trialHo Suk Oh, Jung-Hae Choi, Chan Keum Park, et al.Transfusion|May 21, 2009
Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphomaDok Hyun Yoon, Byeong Seok Sohn, Geundoo Jang, et al.Annals of Hematology|April 26, 2020
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysisSang Eun Yoon, Seok Jin Kim, Dok Hyun Yoon, et al.Cancer Chemotherapy and Pharmacology|February 2, 2013
Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphomaHye Jin Kang, Seung-Sook Lee, Byung Hyun Byun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphomaKen Ohmachi, Nozomi Niitsu, Toshiki Uchida, et al.The American Journal of Surgical Pathology|November 5, 2021
Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell LymphomaJin Roh, Dok Hyun Yoon, Yoon Kyoung Lee, et al.British Journal of Haematology|November 20, 2020
A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levelsHyung-Don Kim, Hyungwoo Cho, Hyehyun Jeong, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 12, 2021
BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosisJin Roh, Hyungwoo Cho, Hyo-Kyung Pak, et al.Investigational New Drugs|August 27, 2013
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomasSeok Jin Kim, Hye Jin Kang, Jin Seok Kim, et al.Pageof 33